Dassault Systèmes Continues to Demonstrate Its Commitment to Life Sciences for Patient Experience by Investing in BioSerenity Dassault Systèmes (Euronext Paris: #13065, DSY.PA) today announced its participation as lead investor in a €65 million Series B financing for BioSerenity, a startup developing a comprehensive and efficient health solution involving textiles June 18, 2019 News